{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:19:41Z","timestamp":1793845181007,"version":"4.6.1"},"reference-count":147,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["2023\/IIRS0063"],"award-info":[{"award-number":["2023\/IIRS0063"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BC200025"],"award-info":[{"award-number":["BC200025"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["2019485"],"award-info":[{"award-number":["2019485"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011302","name":"Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020492","name":"Translational Research Institute Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymthe.2025.05.038","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:47:30Z","timestamp":1748720850000},"page":"4113-4129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights"],"prefix":"10.1016","volume":"33","author":[{"given":"Elaina","family":"Coleborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Ghebosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-8946","authenticated-orcid":false,"given":"Fernando","family":"Souza-Fonseca-Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.05.038_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.it.2018.12.003","article-title":"The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy","volume":"40","author":"Souza-Fonseca-Guimaraes","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.27281","article-title":"Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML","volume":"99","author":"Ciurea","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/neuonc\/noaa047","article-title":"Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma","volume":"22","author":"Khatua","year":"2020","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib6","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-20-0768","article-title":"Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers","volume":"26","author":"Lee","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41587-023-01671-5","article-title":"Industry appetite for natural killer cells intensifies","volume":"41","author":"Sheridan","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.trecan.2022.10.009","article-title":"Weaponizing natural killer cells for solid cancer immunotherapy","volume":"9","author":"Wong","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00073","article-title":"Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function","volume":"11","author":"Rossi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2025.05.038_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2025.05.038_bib12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.05.038_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12260","article-title":"Understanding the extracellular vesicle surface for clinical molecular biology","volume":"11","author":"Hallal","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.it.2022.09.004","article-title":"The cancer cell-derived extracellular vesicle glycocode in immunoevasion","volume":"43","author":"Goncalves","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.trecan.2023.08.006","article-title":"Extracellular vesicle lipids in cancer immunoevasion","volume":"9","author":"Chen","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib18","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","article-title":"Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis","volume":"9","author":"Zeng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.05.038_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1359479","article-title":"Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles","volume":"6","author":"Treps","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","article-title":"Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors","volume":"34","author":"Pavlyukov","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.05.038_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14448","article-title":"MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression","volume":"8","author":"Teng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.05.038_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-\u03b21","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2025.05.038_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14661-w","article-title":"Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia","volume":"7","author":"Hong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.05.038_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12951-018-0372-z","article-title":"Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma","volume":"16","author":"L\u00f3pez-Cobo","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ymthe.2025.05.038_bib26","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib27","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib28","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41467-022-29469-0","article-title":"CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity","volume":"13","author":"Bernareggi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.05.038_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1062968","article-title":"Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-\u03b2 and miR23a transfer","volume":"5","author":"Berchem","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ymthe.2025.05.038_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.176.3.1375","article-title":"Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function","volume":"176","author":"Liu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/cancers11060874","article-title":"Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2025.05.038_bib33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib34","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","article-title":"Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping","volume":"25","author":"Netskar","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105176","article-title":"TGF-b signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer","volume":"104","author":"Wong","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ymthe.2025.05.038_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: a \u2018tag game\u2019 between NK cells and malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00909","article-title":"The Natural Cytotoxicity Receptors in Health and Disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib38","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.4049\/jimmunol.179.9.5977","article-title":"Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1","volume":"179","author":"Yu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib39","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1158\/1078-0432.CCR-09-1720","article-title":"KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma","volume":"15","author":"Venstrom","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.185.4.795","article-title":"NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor","volume":"185","author":"Brooks","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib42","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.05.038_bib43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib44","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural Killer (NK) Cell\u2013mediated Cytotoxicity: Differential Use of TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells","volume":"188","author":"Zamai","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib45","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/sj.onc.1205255","article-title":"IFN\u03b3 sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway","volume":"21","author":"Fulda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.05.038_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor immune evasion arises through loss of TNF sensitivity","volume":"3","author":"Kearney","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1189\/jlb.0611308","article-title":"Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1","volume":"91","author":"Wang","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib48","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1073\/pnas.1221312110","article-title":"Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.05.038_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.seminhematol.2020.10.002","article-title":"Natural killer cell engineering \u2013 a new hope for cancer immunotherapy","volume":"57","author":"Lin","year":"2020","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12309","article-title":"Unraveling multilayered extracellular vesicles: Speculation on cause","volume":"12","author":"Broad","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301010","article-title":"Clinical Translation of Extracellular Vesicles","volume":"12","author":"Ghodasara","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2025.05.038_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101155","article-title":"Extracellular vesicles as personalized medicine","volume":"91","author":"Beetler","year":"2023","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib56","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1111\/ajt.16164","article-title":"Extracellular vesicles for treatment of solid organ ischemia-reperfusion injury","volume":"20","author":"Ali","year":"2020","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.ymthe.2025.05.038_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2020.09.003","article-title":"Extracellular Vesicles in Cancer Detection: Hopes and Hypes","volume":"7","author":"Hu","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib58","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.05.038_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12964-024-01510-3","article-title":"Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look","volume":"22","author":"Abbasi-Malati","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2025.05.038_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091946","article-title":"Glycan Node Analysis of Plasma-Derived Extracellular Vesicles","volume":"9","author":"Walker","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.05.038_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119641","article-title":"High-throughput analysis of glycan sorting into extracellular vesicles","volume":"1871","author":"Pendiuk Goncalves","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12202","article-title":"Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays","volume":"11","author":"Busatto","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.nanolett.3c03579","article-title":"Extracellular Vesicle and Lipoprotein Interactions","volume":"24","author":"Ghebosu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.05.038_bib65","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41556-022-00983-z","article-title":"Opportunities and challenges in studying the extracellular vesicle corona","volume":"24","author":"Buzas","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12951-020-00722-2","article-title":"Brain metastases-derived extracellular vesicles induce binding and aggregation of low-density lipoprotein","volume":"18","author":"Busatto","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ymthe.2025.05.038_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202403199","article-title":"Immunogenicity of Extracellular Vesicles","volume":"36","author":"Xia","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2025.05.038_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2022.100016","article-title":"Sucrose-based cryoprotective storage of extracellular vesicles","volume":"1","author":"Walker","year":"2022","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.ymthe.2025.05.038_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12362","article-title":"Hyaluronic acid: An overlooked extracellular vesicle contaminant","volume":"12","author":"Goncalves","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307240","article-title":"Chemically-Induced Lipoprotein Breakdown for Improved Extracellular Vesicle Purification","volume":"20","author":"Iannotta","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ymthe.2025.05.038_bib72","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/ijc.29664","article-title":"Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer","volume":"137","author":"Duijvesz","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41416-019-0726-9","article-title":"Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival","volume":"122","author":"Nanou","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1340745","article-title":"Characterisation of tumour-derived microvesicles in cancer patients\u2019 blood and correlation with clinical outcome","volume":"6","author":"Menck","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib75","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-07-6538","article-title":"Senescence-Associated Exosome Release from Human Prostate Cancer Cells","volume":"68","author":"Lehmann","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv330","article-title":"Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer","volume":"108","author":"Gobbo","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymthe.2025.05.038_bib77","first-page":"E3234","article-title":"Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.05.038_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-018-0915-z","article-title":"Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules","volume":"37","author":"Boussadia","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib79","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41563-024-02049-x","article-title":"Extracellular vesicle gatekeepers for tumours","volume":"23","author":"Wolfram","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ymthe.2025.05.038_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215751","article-title":"Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis","volume":"548","author":"He","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2025.05.038_bib81","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-021-01448-x","article-title":"Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934\/SHP2 axis in NSCLC","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib82","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.ymthe.2021.04.028","article-title":"Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer","volume":"29","author":"Ning","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.05.038_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah5509","article-title":"Tumor-derived exosomes modulate PD-L1 expression in monocytes","volume":"2","author":"Haderk","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41565-023-01522-z","article-title":"Entry and exit of extracellular vesicles to and from the blood circulation","volume":"19","author":"Iannotta","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115054","article-title":"Vasculature organotropism in drug delivery","volume":"201","author":"Amruta","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.05.038_bib86","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib87","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acsnano.9b10033","article-title":"Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes","volume":"14","author":"Joshi","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.ymthe.2025.05.038_bib88","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ncb2574","article-title":"Active Wnt proteins are secreted on exosomes","volume":"14","author":"Gross","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib89","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2025.05.038_bib90","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor \u03b21 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.05.038_bib91","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/2326-6066.CIR-21-1052","article-title":"TGF\u03b2 and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity","volume":"10","author":"Souza-Fonseca-Guimaraes","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib92","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.4049\/jimmunol.1701461","article-title":"Canonical TGF-\u03b2 Signaling Pathway Represses Human NK Cell Metabolism","volume":"200","author":"Zaiatz-Bittencourt","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib93","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41416-023-02184-3","article-title":"TGF\u03b2 carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinoma","volume":"128","author":"Ludwig","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib94","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41392-023-01711-1","article-title":"Simultaneously targeting extracellular vesicle trafficking and TGF-\u03b2 receptor kinase activity blocks signaling hyperactivation and metastasis","volume":"8","author":"Teixeira","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.05.038_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70055","article-title":"Extracellular Vesicles Secreted by Cancer-Associated Fibroblasts Drive Non-Invasive Cancer Cell Progression to Metastasis via TGF-\u03b2 Signalling Hyperactivation","volume":"14","author":"Teixeira","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib96","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-\u03b3 for TH1 priming","volume":"5","author":"Mart\u00edn-Fontecha","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells \u2014 mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib98","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800195","article-title":"Human NK cell development in hIL-7 and hIL-15 knockin NOD\/SCID\/IL2rgKO mice","volume":"2","author":"Matsuda","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ymthe.2025.05.038_bib99","doi-asserted-by":"crossref","first-page":"E9626","DOI":"10.1073\/pnas.1705301114","article-title":"Humanized mouse model supports development, function, and tissue residency of human natural killer cells","volume":"114","author":"Herndler-Brandstetter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.05.038_bib100","series-title":"Natural Killer (NK) Cells: Methods and Protocols","first-page":"53","article-title":"Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease","author":"Shan","year":"2022"},{"key":"10.1016\/j.ymthe.2025.05.038_bib101","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell\u2013driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.05.038_bib102","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/2326-6066.CIR-19-0483","article-title":"Inhibition of MICA and MICB Shedding Elicits NK-Cell\u2013Mediated Immunity against Tumors Resistant to Cytotoxic T Cells","volume":"8","author":"Ferrari de Andrade","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-Infiltrating Natural Killer Cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2025.05.038_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104811","article-title":"Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation","volume":"96","author":"Lachota","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ymthe.2025.05.038_bib105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib106","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib107","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002044","article-title":"TGF\u03b2 drives NK cell metabolic dysfunction in human metastatic breast cancer","volume":"9","author":"Slattery","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.05.038_bib108","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7527","article-title":"Therapeutic blockade of activin-A improves NK cell function and antitumor immunity","volume":"12","author":"Rautela","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2025.05.038_bib109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.05.038_bib110","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ymthe.2025.05.038_bib111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-17-0604","article-title":"Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Trans-Presentation","volume":"6","author":"Borrelli","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib112","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.oraloncology.2017.11.024","article-title":"Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway","volume":"76","author":"Wang","year":"2018","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib113","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/imcb.12679","article-title":"Sleeping Beauty kit sets provide rapid and accessible generation of artificial antigen-presenting cells for natural killer cell expansion","volume":"101","author":"Dobson","year":"2023","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells","volume":"7","author":"Denman","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymthe.2025.05.038_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70140","article-title":"Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR","volume":"15","author":"Lam","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383281","article-title":"PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival","volume":"15","author":"Oyer","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/cells7120273","article-title":"Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid","volume":"7","author":"Busatto","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.05.038_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101159","article-title":"Extracellular vesicle therapeutics from plasma and adipose tissue","volume":"39","author":"Iannotta","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.ymthe.2025.05.038_bib119","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological Guidelines to Study Extracellular Vesicles","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12033","article-title":"Functional assays to assess the therapeutic potential of extracellular vesicles","volume":"10","author":"Nguyen","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: A systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.05.038_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113961","article-title":"Dosing extracellular vesicles","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.05.038_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151227","article-title":"Commonly used methods for extracellular vesicles\u2019 enrichment: Implications in downstream analyses and use","volume":"101","author":"Clos-Sansalvador","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12929-024-01095-6","article-title":"Increasing the biomolecular relevance of cell culture practice","volume":"32","author":"Ghebosu","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ymthe.2025.05.038_bib125","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-04-1800","article-title":"Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles","volume":"64","author":"Graves","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib126","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.matbio.2017.10.007","article-title":"Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodeling","volume":"75\u201376","author":"Sanderson","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib127","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","article-title":"Rab27a Supports Exosome-Dependent and -Independent Mechanisms That Modify the Tumor Microenvironment and Can Promote Tumor Progression","volume":"72","author":"Bobrie","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib128","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1158\/0008-5472.CAN-22-2220","article-title":"Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors","volume":"83","author":"Zhong","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.05.038_bib129","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s12276-022-00898-7","article-title":"Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/070674375800300401","article-title":"The Treatment of Depressive Conditions with Imipramine (G 22355)","volume":"3","author":"Lehmann","year":"1958","journal-title":"Can. Psychiatr. Assoc. J."},{"key":"10.1016\/j.ymthe.2025.05.038_bib131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00421540","article-title":"Imipramine side effects in children","volume":"37","author":"Saraf","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.ymthe.2025.05.038_bib132","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymthe.2016.10.009","article-title":"Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis","volume":"25","author":"Nishida-Aoki","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.05.038_bib133","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the \u03b1v integrin\/TGF-\u03b2 axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.05.038_bib134","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00262-017-1959-1","article-title":"Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-\u03b2R II and NKG2D","volume":"66","author":"Wang","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.05.038_bib135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib136","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2017.74.3179","article-title":"Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma","volume":"36","author":"Bollard","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.05.038_bib137","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41591-024-03478-6","article-title":"Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies","volume":"31","author":"Jadlowsky","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib138","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.cell.2023.08.041","article-title":"Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells","volume":"186","author":"Tsuchida","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.05.038_bib139","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.05.038_bib140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ymthe.2025.05.038_bib141","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/ph14040356","article-title":"A Simple and Quick Method for Loading Proteins in Extracellular Vesicles","volume":"14","author":"Busatto","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ymthe.2025.05.038_bib142","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.7150\/thno.37097","article-title":"Extracellular vesicle-based drug delivery systems for cancer treatment","volume":"9","author":"Walker","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.05.038_bib143","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10544-019-0396-7","article-title":"Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles","volume":"21","author":"Busatto","year":"2019","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.ymthe.2025.05.038_bib144","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.10.034","article-title":"Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming","volume":"190\u2013191","author":"Zhu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2025.05.038_bib145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41417-021-00352-2","article-title":"Cytokine-enhanced cytolytic activity of exosomes from NK Cells","volume":"29","author":"Enomoto","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2025.05.038_bib146","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00262-022-03161-0","article-title":"Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12\/15\/18","volume":"71","author":"Aarsund","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.05.038_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.977353","article-title":"Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins","volume":"13","author":"Aarsund","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625004058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:39:11Z","timestamp":1788406751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625004058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":147,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525001625004058"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.05.038","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}